Improve Medication Adherence Among Stroke Survivors in Rural Kentucky (NCT07084051) | Clinical Trial Compass
CompletedNot Applicable
Improve Medication Adherence Among Stroke Survivors in Rural Kentucky
United States4 participantsStarted 2025-07-24
Plain-language summary
To test the feasibility and promise of a combined intervention provided by community health worker (CHW) in collaboration with pharmacy technician and pharmacist to improve hypertension and long-term stroke outcomes by identifying and reducing barriers to medication adherence among ischemic stroke survivors. This collaborative intervention involves a self-management program including an educational session on practical strategies to improve hypertension control (i.e., appropriately taking medications, necessity of treatment, and consequences of not taking medicine, etc.), complemented by individually-tailored sessions to identify and address barriers to medication adherence.
Who can participate
Age range
30 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients with history of ischemic stroke or transient ischemic attack (TIA) in the past 2 years
* residing in a rural county in Kentucky
Exclusion Criteria:
* significant aphasia
* cognitive impairment
* a terminal illness
* other neurologic deficits that would impede from providing informed consent or meaningfully participate in the one-to-one sessions.
* a prior aneurysmal subarachnoid hemorrhage and or aneurysm, cerebral venous sinus thrombosis, vasculitis, blood clotting disorder due to genetic causes
* if the patient does not take any secondary preventative medications
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial focused on stroke and TIA survivors in rural Kentucky — does my location or healthcare access situation make the findings from this study relevant to my own medication routine?
2The trial measured changes in medication adherence using a questionnaire — what does that actually mean for me practically, and are there strategies from this kind of research that my care team could apply to help me stick to my stroke prevention medications?
3Since this trial is already completed, has my doctor seen or reviewed any of its results, and do those results suggest any specific approaches to medication adherence that might work better than what I'm currently doing?
4Managing medications after a stroke can be complicated — based on what this study explored, are there tools, reminders, or support programs my doctor could recommend that have been shown to help stroke survivors in situations like mine?
5Is there a reason to prioritize getting my medication adherence on track before considering other interventions, and does research like this change how my doctor thinks about follow-up care after a stroke or TIA?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.